Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 04, 2026
TickeronGET DAILY SIGNALS
Ascent Industries (ACNT) Delivers +37.8% Sales Growth in Q3 2026 Amid Turnaround Efforts

Ascent Industries (ACNT) Delivers +37.8% Sales Growth in Q3 2026 Amid Turnaround Efforts

Key Takeaways

  • Ascent Industries reported third quarter 2026 net sales of $27.1 million, up 37.8% year over year, including 26.3% growth excluding the Midwest Graphic Sales acquisition.
  • Adjusted EBITDA rose to $3.5 million, or 13% of sales, an improvement of roughly $2.1 million from the prior-year quarter.
  • Gross profit increased 21.9% year over year to $7.1 million, with gross margin improving approximately 460 basis points sequentially to 26.2%.
  • Diluted earnings per share from continuing operations reached $0.15, compared with a loss per share of $0.01 in the same quarter a year ago.
  • Operating cash flow turned positive during the quarter, and the company ended September with $28.7 million in cash and no borrowings under its revolving credit facility.

Earnings Context and Why It Matters

Ascent Industries is a specialty chemicals platform focused on developing, producing, and distributing tailored, performance-driven chemical solutions. Its third quarter 2026 results, reported on November 4, 2026, mark an important checkpoint in the company's multi-year effort to grow revenue, expand margins, and convert that growth into cash flow. The quarter reflects the early integration of the Midwest Graphic Sales acquisition while also demonstrating meaningful organic expansion in the base business. For investors, the report matters because it shows whether ACNT can sustain top-line momentum while simultaneously improving profitability and liquidity — a combination that has historically been difficult for the company to deliver consistently. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Reported Results

Ascent Industries reported third quarter 2026 net sales of $27.1 million, an increase of 37.8% from $19.7 million in the prior-year period. Excluding the Midwest Graphic Sales acquisition, sales still grew 26.3% on an organic basis, reflecting broad-based demand across the business.

Gross profit climbed 21.9% year over year to $7.1 million. Gross margin reached 26.2%, improving approximately 460 basis points sequentially, although it remained below the prior-year level due primarily to higher material costs. Selling, general, and administrative (SG&A) expenses declined to $5.3 million, or 19.6% of revenue, compared with 31.7% a year earlier — a clear sign of operating leverage.

Adjusted EBITDA increased to $3.5 million, or 13% of sales, from $1.4 million, or 7% of sales, in the prior-year quarter. Diluted earnings per share from continuing operations came in at $0.15, versus a loss of $0.01 per share a year ago. The company ended the quarter with $28.7 million in cash and no outstanding borrowings under its revolving credit facility, with $21.1 million of remaining availability. From what I see, the balance sheet position stands out as particularly clean.

Market Reaction and Investor Sentiment

ACNT entered its third quarter report on improving operational footing, with management emphasizing a trailing twelve-month view of the business given normal quarterly variability. The headline 37.8% sales increase, the swing to positive operating cash flow, and the meaningful improvement in Adjusted EBITDA are likely to be interpreted by investors as evidence that the company's turnaround is gaining traction. That said, gross margin still trailed the prior-year period, and management cautioned that normal program turnover and seasonality could affect results heading into year-end and the first quarter. Investor sentiment will likely hinge on whether the company can sustain this margin and cash-flow momentum rather than treating the quarter as a one-time improvement.

Forward Outlook and Key Factors to Monitor

Following this report, investors should watch whether Ascent Industries can make its recent progress more consistent and durable. Management's stated goal is to convert the growth already in the business into stronger margins, cash flow, and returns, with a long-term target of SG&A near 15% of revenue as the revenue base expands.

Margin expansion will be a central focus. Gross margin improved sequentially but remained below the prior-year quarter due to higher material costs, so sourcing initiatives, process consistency, automation, and asset utilization will be key levers to monitor. On a trailing twelve-month basis, the company reported approximately $91 million in revenue from continuing operations, up more than 22% year over year, with Adjusted EBITDA improving to about $2.9 million from roughly break-even a year earlier.

Liquidity and cash conversion also deserve attention. Operating cash flow turned positive in the quarter, and the company received a $4.55 million Bristol Metals escrow holdback after quarter end, which it expects to lift cash into the low-to-mid $30 million range. Management estimates that each five-day improvement in the cash conversion cycle could release roughly $1 million to $1.5 million of cash. Looking ahead, investors will likely focus on integration of the Midwest Graphic Sales acquisition, demand trends across the specialty chemicals portfolio, and whether the company continues to deploy capital through share repurchases while preserving balance-sheet flexibility. I’m watching this closely for signs of sustained execution.

Exploring AI Tools for Stock Analysis

One tool I turn to regularly is Tickeron’s AI Screener, which helps me filter stocks and ETFs by technical patterns, fundamentals, and AI-driven signals. It makes it easier to compare names like ACNT against sector peers without spending hours on manual work. I find it especially useful when evaluating turnaround stories in specialty chemicals, as it surfaces comparable opportunities based on customizable criteria such as industry, market cap, and performance metrics. This approach keeps my research efficient while highlighting ideas that align with the trends I’m already tracking in the space.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ACNT

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ACNT's RSI Oscillator recovers from oversold territory

The RSI Indicator for ACNT moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 20 of the 22 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ACNT just turned positive on October 20, 2026. Looking at past instances where ACNT's MACD turned positive, the stock continued to rise in 34 of 51 cases over the following month. The odds of a continued upward trend are 67%.

Following a +1.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACNT advanced for three days, in 171 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 65 cases where ACNT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 65%.

The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACNT as a result. In 69 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

The Aroon Indicator for ACNT entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.555) is normal, around the industry mean (2.450). P/E Ratio (-30.533) is within average values for comparable stocks, (-17.964). Projected Growth (PEG Ratio) (0.200) is also within normal values, averaging (1.548). Dividend Yield (0.073) settles around the average of (0.040) among similar stocks. P/S Ratio (1.661) is also within normal values, averaging (48.960).

The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. ACNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.82B. The market cap for tickers in the group ranges from 50 to 241.89B. LIN holds the highest valuation in this group at 241.89B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -1%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -7%. SNES experienced the highest price growth at 25%, while YMAT experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 62%. For the same stocks of the Industry, the average monthly volume growth was 50% and the average quarterly volume growth was -42%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 54
Price Growth Rating: 53
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of welded stainless steel pipe and specialty chemicals

Industry ChemicalsSpecialty

Industry
Miscellaneous Manufacturing
Address
20 N. Martingale Road
Phone
+1 603 884-9181
Employees
198
Web
https://www.ascentco.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
RBLX shares plunged approximately 24% in premarket trading on Friday, May 1, 2026, falling roughly $13.36 to around $41.90 from the prior close of approximately $55.26. The primary catalyst was a dramatic cut to full-year 2026 bookings guidance, slashed to $7.33B–$7.60B from $8.28B–$8.55B.
SMMT shares fell approximately 20% in premarket trading on Friday, May 1, 2026, dropping from a prior close of approximately $20.83 to around $16.66. The primary catalyst was the HARMONi-3 interim PFS analysis miss, with the Phase III global trial failing to meet expectations for its squamous cohort, undermining the ivonescimab thesis.